BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

252 related articles for article (PubMed ID: 10493164)

  • 1. JTE-607, a novel inflammatory cytokine synthesis inhibitor without immunosuppression, protects from endotoxin shock in mice.
    Kakutani M; Takeuchi K; Waga I; Iwamura H; Wakitani K
    Inflamm Res; 1999 Aug; 48(8):461-8. PubMed ID: 10493164
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Comparative study of glucocorticoids, cyclosporine A, and JTE-607 [(-)-Ethyl-N[3,5-dichloro-2-hydroxy-4-[2-(4-methylpiperazin-1-yl)ethoxy]benzoyl]-L-phenylalaninate dihydrochloride] in a mouse septic shock model.
    Iwamura H; Sato M; Wakitani K
    J Pharmacol Exp Ther; 2004 Dec; 311(3):1256-63. PubMed ID: 15280441
    [TBL] [Abstract][Full Text] [Related]  

  • 3. JTE-607, a cytokine release blocker, attenuates acid aspiration-induced lung injury in rats.
    Jian MY; Koizumi T; Tsushima K; Kubo K
    Eur J Pharmacol; 2004 Mar; 488(1-3):231-8. PubMed ID: 15044056
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Beneficial effects of SK&F 105809, a novel cytokine-suppressive agent, in murine models of endotoxin shock.
    Olivera DL; Esser KM; Lee JC; Greig RG; Badger AM
    Circ Shock; 1992 Aug; 37(4):301-6. PubMed ID: 1446388
    [TBL] [Abstract][Full Text] [Related]  

  • 5. IFN-gamma is a master regulator of endotoxin shock syndrome in mice primed with heat-killed Propionibacterium acnes.
    Kawa K; Tsutsui H; Uchiyama R; Kato J; Matsui K; Iwakura Y; Matsumoto T; Nakanishi K
    Int Immunol; 2010 Mar; 22(3):157-66. PubMed ID: 20130231
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Effects of a cytokine inhibitor, JTE-607, on the response to endotoxin in healthy human volunteers.
    Borozdenkova S; Mant TG; Allen E; Pu K; Hoshino S; Jurcevic S
    Int Immunopharmacol; 2011 Nov; 11(11):1837-43. PubMed ID: 21820084
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Cilostazol protects mice against endotoxin shock and attenuates LPS-induced cytokine expression in RAW 264.7 macrophages via MAPK inhibition and NF-kappaB inactivation: not involved in cAMP mechanisms.
    Park WS; Jung WK; Lee DY; Moon C; Yea SS; Park SG; Seo SK; Park C; Choi YH; Kim GY; Choi JS; Choi IW
    Int Immunopharmacol; 2010 Sep; 10(9):1077-85. PubMed ID: 20601185
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The resistance of P. acnes--primed interferon gamma-deficient mice to low-dose lipopolysaccharide-induced acute liver injury.
    Shimizu Y; Margenthaler JA; Landeros K; Otomo N; Doherty G; Flye MW
    Hepatology; 2002 Apr; 35(4):805-14. PubMed ID: 11915026
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Prophylactic effect of JTE-607 on LPS-induced acute lung injury in rats with CINC-1 inhibition.
    Iwamura H; Inushima K; Takeuchi K; Kakutani M; Wakitani K
    Inflamm Res; 2002 Mar; 51(3):160-6. PubMed ID: 12005207
    [TBL] [Abstract][Full Text] [Related]  

  • 10. LYATK1 potently inhibits LPS-mediated pro-inflammatory response.
    Xi F; Liu Y; Wang X; Kong W; Zhao F
    Biochem Biophys Res Commun; 2016 Jan; 470(1):1-8. PubMed ID: 26620228
    [TBL] [Abstract][Full Text] [Related]  

  • 11. JTE-607, a multiple cytokine production inhibitor, ameliorates disease in a SCID mouse xenograft acute myeloid leukemia model.
    Uesato N; Fukui K; Maruhashi J; Tojo A; Tajima N
    Exp Hematol; 2006 Oct; 34(10):1385-92. PubMed ID: 16982331
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Pharmacological properties of JTE-052: a novel potent JAK inhibitor that suppresses various inflammatory responses in vitro and in vivo.
    Tanimoto A; Ogawa Y; Oki C; Kimoto Y; Nozawa K; Amano W; Noji S; Shiozaki M; Matsuo A; Shinozaki Y; Matsushita M
    Inflamm Res; 2015 Jan; 64(1):41-51. PubMed ID: 25387665
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Therapeutic effects of TAK-242, a novel selective Toll-like receptor 4 signal transduction inhibitor, in mouse endotoxin shock model.
    Sha T; Sunamoto M; Kitazaki T; Sato J; Ii M; Iizawa Y
    Eur J Pharmacol; 2007 Oct; 571(2-3):231-9. PubMed ID: 17632100
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Effects of post-treatment with low-dose propofol on inflammatory responses to lipopolysaccharide-induced shock in conscious rats.
    Hsu BG; Yang FL; Lee RP; Peng TC; Chen HI
    Clin Exp Pharmacol Physiol; 2005; 32(1-2):24-9. PubMed ID: 15730430
    [TBL] [Abstract][Full Text] [Related]  

  • 15. A novel synthetic derivative of melatonin, 5-hydroxy-2'-isobutyl-streptochlorin (HIS), inhibits inflammatory responses via regulation of TRIF-dependent signaling and inflammasome activation.
    Shim DW; Shin HJ; Han JW; Ji YE; Jang CH; Koppula S; Kang TB; Lee KH
    Toxicol Appl Pharmacol; 2015 Apr; 284(2):227-35. PubMed ID: 25689174
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Antimicrobial cathelicidin polypeptide CAP11 suppresses the production and release of septic mediators in D-galactosamine-sensitized endotoxin shock mice.
    Murakami T; Obata T; Kuwahara-Arai K; Tamura H; Hiramatsu K; Nagaoka I
    Int Immunol; 2009 Aug; 21(8):905-12. PubMed ID: 19556302
    [TBL] [Abstract][Full Text] [Related]  

  • 17. A novel cyclohexene derivative, ethyl (6R)-6-[N-(2-Chloro-4-fluorophenyl)sulfamoyl]cyclohex-1-ene-1-carboxylate (TAK-242), selectively inhibits toll-like receptor 4-mediated cytokine production through suppression of intracellular signaling.
    Ii M; Matsunaga N; Hazeki K; Nakamura K; Takashima K; Seya T; Hazeki O; Kitazaki T; Iizawa Y
    Mol Pharmacol; 2006 Apr; 69(4):1288-95. PubMed ID: 16373689
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Chloroquine inhibits production of TNF-alpha, IL-1beta and IL-6 from lipopolysaccharide-stimulated human monocytes/macrophages by different modes.
    Jang CH; Choi JH; Byun MS; Jue DM
    Rheumatology (Oxford); 2006 Jun; 45(6):703-10. PubMed ID: 16418198
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Enhancement of endotoxin-induced interleukin-10 production by SR 31747A, a sigma ligand.
    Bourrie B; Bouaboula M; Benoit JM; Derocq JM; Esclangon M; Le Fur G; Casellas P
    Eur J Immunol; 1995 Oct; 25(10):2882-7. PubMed ID: 7589087
    [TBL] [Abstract][Full Text] [Related]  

  • 20. MPLA shows attenuated pro-inflammatory properties and diminished capacity to activate mast cells in comparison with LPS.
    Schülke S; Flaczyk A; Vogel L; Gaudenzio N; Angers I; Löschner B; Wolfheimer S; Spreitzer I; Qureshi S; Tsai M; Galli S; Vieths S; Scheurer S
    Allergy; 2015 Oct; 70(10):1259-68. PubMed ID: 26081583
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 13.